Attached files
file | filename |
---|---|
S-1 - FORM S-1 - CNS Pharmaceuticals, Inc. | cns_s1.htm |
EX-5.1 - LEGAL OPINION - CNS Pharmaceuticals, Inc. | cns_ex0501.htm |
EX-4.4 - FORM OF PRE-FUNDED COMMON STOCK PURCHASE WARRANT - CNS Pharmaceuticals, Inc. | cns_ex0404.htm |
EX-1.1 - FORM OF UNDERWRITING AGREEMENT - CNS Pharmaceuticals, Inc. | cns_ex0101.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in this Registration Statement on Form S-1 of our report dated March 12, 2020 with respect to the audited financial statements of CNS Pharmaceuticals, Inc. as of and for the year ended December 31, 2019.
We also consent to the references to us under the heading “Experts” in such Registration Statement.
/s/ MaloneBailey, LLP
www.malonebailey.com
Houston, Texas
December 21, 2020